^
    1year
    A First-in-Human Study to Evaluate the Safety and Tolerability of HH3806 in Patients With Advanced Tumors (ACTRN12622001339741)
    P1, N=36, Recruiting, Tigermed Australia Pty Ltd | Initiation date: Mar 2000 --> Mar 2023
    Trial initiation date • Metastases
    |
    HH3806